IRCT138706051096N1
Completed
Phase 3
Evaluation of the effect of vaginal Progesterone in preventing preterm labor
Vice Chancellor for research-Guilan University of Medical Sciences0 sites260 target enrollmentTBD
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- prevention of preterm labor.
- Sponsor
- Vice Chancellor for research-Guilan University of Medical Sciences
- Enrollment
- 260
- Status
- Completed
- Last Updated
- 8 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Pregnant women were eligible to enter the trial if 1\) they were between 26\-36 weeks of gestation based on their LMP or sonography before 16 weeks of gestation. 2\) Confirmation of premature delivery with a)uterine contractions more than 30 seconds and three or more contractions per 30 minutes established by tochodynamometer b) cervical dilatation of 0\-2 cm in nulliparous and 1 \-2 cm in multiparous and cervical effacement greater than 50% 3\) intact membrane.
- •Exclusion criteria included: 1\) unwillingness or inability to comply with study procedures before 36 weeks of gestation 2\) lack of useful sufficient data 3\) preeclampsia requiring termination of pregnancy.
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Evaluation of the effect of vaginal progesterone administration on ultrasonographic indicators and fetal and pregnancy outcomes of women at high risk of preeclampsiaHigh risk pregnancy.Supervision of high risk pregnancyIRCT20151228025732N72Semnan University of Medical Sciences60
Completed
Phase 2
Vaginal Progesterone effect on pregnancy rate in infertility women with polycystic ovarian syndromeInfertility and Polycystic Ovarian Syndrome.Polycystic ovarian syndromeIRCT201206072967N4Vice chancellor of research, Kashan University of Medical Sciences200
Active, not recruiting
Phase 1
The Effect of Vaginal Progesterone Administration in the prevention of Preterm Birth in Women with Short Cervix, [also Known as: Vaginal progesterone bioadhesive gel (Prochieve)® Extending Gestation A New Therapy for Short Cervix-Trial (PREGNANT Short Cervix-Trial)] - PREGNANT Short Cervix-TrialPreterm birth (less than or equal to 32 6/7 weeks gestation)EUCTR2008-007498-19-CZColumbia Laboratories, Inc450
Recruiting
Phase 3
Comparison of the effect of vaginal progesterone on uterine Doppler findings in early-onset preeclampsiaIRCT20210127050156N1Karaj University of Medical Sciences80
Completed
Not Applicable
the effect of progesterone in the prevention of preterm deliveryComplications of labour and delivery.Preterm spontaneous labour with preterm deliveryIRCT2015040921670N1Vice Chancellor for Research of Shahid Sadoughi University of Medical Sciences76